Eurofins Scientific SEEURONEXT: ERF

Eurofins Scientific: Director/PDMR Shareholding

· Issued by Eurofins Scientific SE via Business Wire

Summary by 6ix AI

Brian Williams, Group EVP and Member of the Group Operating Council at Eurofins Scientific SE, a bio-analysis testing company, exercised 24000 stock options under the Eurofins stock option program and sold 24000 shares, both on November 5, 2026.

Key details

  • The 24000 shares were sold at a price of EUR 87.5769 each, for an aggregated EUR 2,101,845.60.
  • The option exercise took place off-exchange, and the share sale took place on the Euronext Paris stock exchange.
  • The sale is linked to the Eurofins stock option program.
  • Eurofins Scientific made the disclosure as a dealing by a person discharging managerial responsibilities (a senior manager) under the European Market Abuse Regulation, the EU rules requiring such trades to be made public.

6ix AI wrote this summary from the release below and checked it against the release.

Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.

This notification is made in accordance with the European Market Abuse Regulation.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Brian Williams

2.

Reason for the notification

a)

Position / status

Group EVP/ Member of Group Operating Council

b)

Initial notification / amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Eurofins Scientific S.E.

b)

LEI

529900JEHFM47DYY3S57

4.

Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Share

Identification code

ISIN: FR0014000MR3

b)

Nature of the transaction

Exercise of stock options under the Eurofins stock option program. Number of options exercised: 24000

Transaction is linked to the Eurofins stock option / free share / stock option program

c)

Price(s) and volume(s)

Price(s)

Volume(s)

n/a

24000

d)

Aggregated information

— Aggregated volume

n/a

— Price

n/a

e)

Date of the transaction

2026-11-05

g)

Place of the transaction

XOFF

4.

Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Share

Identification code

ISIN: FR0014000MR3

b)

Nature of the transaction

Sale of shares

Transaction is linked to the Eurofins stock option / free share / stock option program

c)

Price(s) and volume(s)

Price(s)

Volume(s)

EUR 87.5769

24000

d)

Aggregated information

— Aggregated volume

EUR 2,101,845.60

— Price

EUR 87.5769

e)

Date of the transaction

2026-11-05

g)

Place of the transaction

XPAR

About Eurofins – the global leader in bio-analysis

Eurofins is Testing for Life. With over 65,000 staff across a network of more than 950 laboratories in over 1,000 companies in 57 countries, Eurofins offers a portfolio of over 200,000 analytical methods.

Eurofins Scientific S.E. shares are listed on Euronext Paris Stock Exchange.

View original source (Business Wire)Eurofins Scientific SE on 6ix

Earlier from Eurofins Scientific

Later from Eurofins Scientific

All Eurofins Scientific news releases